Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Allakos Inc. - Common Stock (NQ: ALLK )

0.8555 -0.0545 (-5.99%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Allakos Inc. - Common Stock

< Previous 1 2 3 4 Next >
After Disappointing Data, Allakos Discontinues Work On Lirentelimab In Eosinophilic Gastrointestinal Diseases
Allakos Inc (NASDAQ: ALLK) has reported data from the EoDyssey Phase 3 study of lirentelimab in patients with eosinophilic duodenitis (EoD).  
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday
Gainers 
Via Benzinga
What 4 Analyst Ratings Have To Say About Allakos
Allakos (NASDAQ:ALLK) has observed the following analyst ratings within the last quarter: 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
Major Indexes Look To Wrap Up Wild August With Losses
Just off a three-day rout, stocks are failing to maintain their morning momentum, with all three major indexes erasing earlier gains to trade in the red at midday. 
Via Talk Markets
Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in... 
Via Benzinga
Peering Into Allakos's Recent Short Interest
Allakos's (NASDAQ:ALLK) short percent of float has fallen 23.25% since its last report. The company recently reported that it has 2.12 million shares sold short, which is 5.48% of... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers 
Via Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year... 
Via Benzinga
Dow Jones Turns Lower; Revlon Shares Jump
U.S. stocks pared gains midway through trading, with the Dow Jones dropping around 100 points on Friday. 
Via Benzinga
89 Biggest Movers From Friday
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
33 Stocks Moving In Friday's Mid-Day Session
Gainers Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 59 stocks hit new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street
Pre-open movers 
Via Benzinga
5 Stocks To Watch For May 9, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
Recap: Allakos Q1 Earnings
Allakos (NASDAQ:ALLK) reported its Q1 earnings results on Friday, May 6, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Allakos missed estimated earnings by... 
Via Benzinga
Analyst Ratings For Allakos
Within the last quarter, Allakos (NASDAQ:ALLK) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 0... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
Via Benzinga
5 Important Investing Lessons From Allakos’ Price Collapse
ALLK stock is a gamble now even after falling about 85% off its 52-week high. Allakos' slide offers investors with a learning opportunity. 
Via InvestorPlace
Allakos Is a Cautionary Tale of Biopharmaceutical Investing
ALLK stock dropped off a cliff following disappointing study results, which illustrates what can go wrong in risky biopharma equities. 
Via InvestorPlace
After a Clinical-Data Bombshell, Allakos Might Actually Be a Buy
After a well-publicized clinical-data letdown, it may be time to go long as the worst-case scenario has already been priced into ALLK stock. 
Via InvestorPlace
(ALLK) - Analyzing Allakos Inc's Short Interest
Allakos Inc's (NASDAQ:ALLK) short percent of float has fallen 26.46% since last its last report. The company recently reported that it has 1.69 million shares sold short, which is... 
Via Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating... 
Via Benzinga
54 Biggest Movers From Thursday
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of... 
Via Benzinga
Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide
Toward the end of trading Thursday, the Dow traded up 0.77% to 36,030 while the NASDAQ rose 1% to 15,677. The S&P also rose, gaining 0.81% to 4,734.65. The U.S. has the... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Pasithea Therapeutics (NASDAQ: 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.